BioPharma Dive February 3, 2025
Kelly Bilodeau

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

An H5N1 outbreak is killing flocks of wild birds in Massachusetts and sickening dairy cows in 16 states while a new strain of H5N9 bird flu has emerged in California. As bird flu continues to spread among animals, experts are on high alert for the possibility of the virus acquiring the ability to trigger an outbreak in humans.

For now, the risk to people is still low, even with a new strain on the rise.

“While the 67 human avian influenza cases can be tracked back to an animal source, there has been no reported human-to-human transmission — if...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
Beam base editing therapy gets ‘proof of concept’ in rare lung disease
The essential biotech news stories of the day
GLP-1s and total joint replacement: 10 things to know
Sun Pharma buys Checkpoint and its new cancer drug
Beam launches $500m financing on base-editing trial data

Share This Article